SANTO
Member of Polpharma Group
With its portfolio that includes over 240
generic drugs which are used in 12 different therapeutic categories for
treatment of diseases in various therapeutic fields.
SANTO Company is one of the leaders of the
pharmaceutical market of Kazakhstan.
The Company currently implements the
largest investment project on the modernization of existing pharmaceutical
industries in accordance with GMP international standards, the investment
volume of which is about 108 million US dollars.
The company has certificates of compliance
with the international standard of good manufacturing practice (GMP) for the
production site and certificate of compliance with the standard of good
distribution practice (GDP) of the company's pharmacy warehouse.
The company exports its products into the markets of 8 countries: Russia, Ukraine, Kyrgyzstan, Mongolia, Uzbekistan, Turkmenistan, Tajikistan, and fulfills requirements for the domestic market.
Link to the company’s website: http://www.santo.kz/